Chronic lymphocytic leukemia diagnosis: how many more algorithms and scoring systems do we need?
作者信息
Matos Daniel Mazza
机构信息
Flow Cytometry Section, Cell Processing Center (CPC), Center of Hematology and Hemotherapy of Ceará (HEMOCE), Fortaleza, Ceará, Brazil.
出版信息
Hematol Transfus Cell Ther. 2025 Jan-Mar;47(1):103668. doi: 10.1016/j.htct.2024.05.007. Epub 2024 Aug 3.
Abstract
摘要
相似文献
1
Chronic lymphocytic leukemia diagnosis: how many more algorithms and scoring systems do we need?慢性淋巴细胞白血病的诊断：我们还需要多少算法和评分系统？
Hematol Transfus Cell Ther. 2025 Jan-Mar;47(1):103668. doi: 10.1016/j.htct.2024.05.007. Epub 2024 Aug 3.
2
Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病的诊断与治疗：巴西慢性淋巴细胞白血病研究组的建议
Rev Bras Hematol Hemoter. 2016 Oct-Dec;38(4):346-357. doi: 10.1016/j.bjhh.2016.07.004. Epub 2016 Aug 20.
3
Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia.慢性淋巴细胞白血病预后生物标志物和风险评分系统的最新进展
Biomark Res. 2020 Sep 7;8:40. doi: 10.1186/s40364-020-00222-3. eCollection 2020.
4
Machine learning applications in the diagnosis of leukemia: Current trends and future directions.机器学习在白血病诊断中的应用：现状与未来方向。
Int J Lab Hematol. 2019 Dec;41(6):717-725. doi: 10.1111/ijlh.13089. Epub 2019 Sep 9.
5
Explainable machine learning for chronic lymphocytic leukemia treatment prediction using only inexpensive tests.仅使用廉价检测指标进行慢性淋巴细胞白血病治疗预测的可解释机器学习
Comput Biol Med. 2022 Jun;145:105490. doi: 10.1016/j.compbiomed.2022.105490. Epub 2022 Apr 6.
6
Differentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group.根据临床结果区分慢性淋巴细胞白血病与单克隆 B 淋巴细胞增多症：代表意大利血液肿瘤学会慢性淋巴增殖性疾病工作组。
Haematologica. 2011 Feb;96(2):277-83. doi: 10.3324/haematol.2010.030189. Epub 2010 Oct 22.
7
Revolutionizing chronic lymphocytic leukemia diagnosis: A deep dive into the diverse applications of machine learning.颠覆慢性淋巴细胞白血病诊断：机器学习的多元应用深度解析
Blood Rev. 2023 Nov;62:101134. doi: 10.1016/j.blre.2023.101134. Epub 2023 Sep 22.
8
Surface-antigen expression profiling of B cell chronic lymphocytic leukemia: from the signature of specific disease subsets to the identification of markers with prognostic relevance.B细胞慢性淋巴细胞白血病的表面抗原表达谱分析：从特定疾病亚群的特征到具有预后相关性标志物的鉴定
J Transl Med. 2006 Mar 1;4:11. doi: 10.1186/1479-5876-4-11.
9
Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia.慢性淋巴细胞白血病预后指数：一种预测中国慢性淋巴细胞白血病患者首次治疗时间的新型综合评分系统。
Chin Med J (Engl). 2017 Jan 20;130(2):135-142. doi: 10.4103/0366-6999.197978.
10
The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experience.用于预测早期慢性淋巴细胞白血病首次治疗时间的预后指数的效用：GIMEMA 经验。
Haematologica. 2010 Mar;95(3):464-9. doi: 10.3324/haematol.2009.011767. Epub 2009 Nov 10.
引用本文的文献
1
What Is Acute Myeloid Leukemia?什么是急性髓系白血病？
EJHaem. 2025 May 25;6(3):e70063. doi: 10.1002/jha2.70063. eCollection 2025 Jun.
本文引用的文献
1
CD5-negative chronic lymphocytic leukemia: Does this entity really exist?CD5阴性慢性淋巴细胞白血病：这个实体真的存在吗？
Cytometry B Clin Cytom. 2024 Mar;106(2):126-137. doi: 10.1002/cyto.b.22151. Epub 2023 Nov 28.
2
Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders.流式细胞术分类白血病性淋巴增殖性疾病的方法学和概念挑战。
Crit Rev Clin Lab Sci. 2023 Mar;60(2):83-100. doi: 10.1080/10408363.2022.2114418. Epub 2022 Sep 6.
3
A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry.一种使用流式细胞术免疫表型分析的慢性淋巴细胞白血病新型鉴别诊断算法。
Hematol Transfus Cell Ther. 2023 Apr-Jun;45(2):176-181. doi: 10.1016/j.htct.2021.08.012. Epub 2021 Nov 29.
4
Overlap between CD23 and CD200 in leukemic lymphoproliferative disorders.白血病性淋巴细胞增生性疾病中CD23与CD200的重叠。
Int J Lab Hematol. 2022 Aug;44(4):e149-e152. doi: 10.1111/ijlh.13791. Epub 2022 Jan 9.
5
A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.一种包含 CD43 和 CD180 的新评分：提高了非典型慢性淋巴细胞白血病的诊断价值。
Cancer Med. 2021 Jul;10(13):4387-4396. doi: 10.1002/cam4.3983. Epub 2021 Jun 1.
6
Concordance between flow cytometry CLL scores.流式细胞术 CLL 评分的一致性。
Int J Lab Hematol. 2021 Aug;43(4):743-751. doi: 10.1111/ijlh.13567. Epub 2021 May 4.
7
FMOD expression in whole blood aids in distinguishing between chronic lymphocytic leukemia and other leukemic lymphoproliferative disorders. A pilot study.全血中 FMOD 的表达有助于鉴别慢性淋巴细胞白血病与其他白血病性淋巴增殖性疾病。一项初步研究。
Cytometry B Clin Cytom. 2020 Sep;98(5):421-428. doi: 10.1002/cyto.b.21890. Epub 2020 Jun 12.
8
Refining the Limits of Borderline Lymphoproliferative Disorders.细化界线性淋巴增生性疾病的界限。
Cytometry B Clin Cytom. 2019 Sep;96(5):351-358. doi: 10.1002/cyto.b.21760. Epub 2018 Dec 28.
9
CD200 included in a 4-marker modified Matutes score provides optimal sensitivity and specificity for the diagnosis of chronic lymphocytic leukaemia.包含在四标记改良马图斯评分中的CD200为慢性淋巴细胞白血病的诊断提供了最佳的敏感性和特异性。
Hematol Oncol. 2018 Mar 30. doi: 10.1002/hon.2510.
10
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project.通过流式细胞术实现慢性淋巴细胞白血病的可重现诊断：欧洲慢性淋巴细胞白血病研究倡议（ERIC）和欧洲临床细胞分析学会（ESCCA）的一项协调项目。
Cytometry B Clin Cytom. 2018 Jan;94(1):121-128. doi: 10.1002/cyto.b.21595. Epub 2018 Jan 17.
Zotero 插件